Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 17, 2020
- Accepted August 27, 2020
- Published online October 2, 2020.
Article Versions
- You are currently viewing a previous version of this article (October 2, 2020 - 04:27).
- View the most recent version of this article
Copyright & Usage
Copyright ©ERS 2020 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Nazanin Z. Kermani1,
- Stelios Pavlidis1,2,
- Jiaxing Xie2,
- Kai Sun1,
- Matthew Loza3,
- Fred Baribaud3,
- Steve J Fowler4,
- Dominic E. Shaw5,
- Louise J. Fleming2,
- Peter H. Howarth6,
- Ana R Sousa7,
- Julie Corfield8,
- Charles Auffray9,
- Bertrand De Meulder9,
- Peter J Sterk10,
- Yike Guo1,
- Mohib Uddin11,
- Ratko Djukanovic6,
- Ian M. Adcock1,2 and
- Kian Fan Chung1,2
- on behalf of the U-BIOPRED study group
- 1Department of Computing & Data Science Institute, Imperial College London, London, United Kingdom
- 2National Heart & Lung Institute, Imperial College London, & Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom
- 3Janssen Research and Development, High Wycombe, Buckinghamshire, United Kingdom
- 4Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, University of Manchester and University Hospital of South Manchester, Manchester, United Kingdom
- 5 Respiratory Research Unit, University of Nottingham, Nottingham, UK
- 6NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, Southampton, UK
- 7Respiratory Therapeutic Unit, GSK, Stockley Park, UK
- 8AstraZeneca R&D Molndal, Sweden and Areteva R&D, Nottingham, UK
- 9European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM, Lyon, France
- 10Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- 11Respiratory Global Medicines Development, AstraZeneca, Gothenburg, Sweden
- Professor K F Chung, National Heart & Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. E-mail: f.chung{at}imperial.ac.uk
Funding
Innovative Medicines Initiative Joint Undertaking
grant agreement 115010